| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Oct―02 |
A digital intervention for cognitive deficits following COVID-19: a randomized clinical trial |
Lindsay W. Victoria, Lauren E. Oberlin, Irena P. Ilieva, Abhishek Jaywant, Dora Kanellopoulos, Catherine Mercaldi, Caitlin A. Stamatis, Deborah N. Farlow, Scott H. Kollins, Ochuwa Tisor, Sama Joshi, Raura Doreste-Mendez, Roy H. Perlis, Faith M. Gunning |
| 2 |
[GO] |
2022―Feb―21 |
Neuropsychopharmacology (NPP) 2020 report on gender balance among corresponding authors and reviewers: before and during the COVID-19 pandemic |
Sofiya Hupalo, Keri Martinowich, William A. Carlezon, Chloe J. Jordan |
| 3 |
[GO] |
2021―Mar―22 |
The impact of COVID-19 on cognition in severe cases highlights the need for comprehensive neuropsychological evaluations in all survivors |
Katherine E. Burdick, Caitlin E. Millett |
| 4 |
[GO] |
2021―Feb―17 |
Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19 |
Abhishek Jaywant, W. Michael Vanderlind, George S. Alexopoulos, Chaya B. Fridman, Roy H. Perlis, Faith M. Gunning |
| 5 |
[GO] |
2021―Jan―21 |
Telemedicine for treating mental health and substance use disorders: reflections since the pandemic |
Alisa B. Busch, Dawn E. Sugarman, Lisa E. Horvitz, Shelly F. Greenfield |
| 6 |
[GO] |
2020―Sep―23 |
Effects of the COVID-19 pandemic on gender representation among corresponding authors of Neuropsychopharmacology (NPP) manuscripts: submissions during January-June, 2020 |
Chloe J. Jordan, William A. Carlezon |
| 7 |
[GO] |
2020―Aug―13 |
Covid-19 and promising solutions to combat symptoms of stress, anxiety and depression |
Deniz Vatansever, Shouyan Wang, Barbara J. Sahakian |
